Chemotherapy of human tumor xenografts in genetically athymic mice

A series of studies were undertaken to evaluate the chemotherapeutic response to various antineoplastic drugs of human breast (MX-1) or colon (CX-2) tumor xenografts growing in genetically athymic (nude) mice. Fragments (2mm3) of either tumor type were implanted subcutaneously into the subaxillary region of NIH Swiss nude mice, and single drug therapy was started when tumors became palpable and were growing progressively. 5-Fluorouracil (5-FU) administered on a Q7DX3 schedule starting on Day 21 post tumor implantation elicited significant retardation in the growth rate of CX-2 tumor. A single treatment with methyl-CCNU induced temporary tumor regression. Against MX-1 tumor, both cyclophosphamide and melphalan induced tumor regressions with no recurrence. 5-FU slowed but did not arrest growth of MX-1 tumor. These tumor systems grown in nude mice appear to be suitable models for in vivo screening of anticancer agents that would prove clinically active.

This article has been cited by other articles:

				I. N. Buhtoiarov, Z. C. Neal, J. Gan, T. N. Buhtoiarova, M. S. Patankar, J. A. A. Gubbels, J. A. Hank, B. Yamane, A. L. Rakhmilevich, R. A. Reisfeld, et al. Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting J. Leukoc. Biol., April 1, 2011; 89(4): 625 - 638. [Abstract] [Full Text] [PDF]

				A. Ido, H. Uto, A. Moriuchi, K. Nagata, Y. Onaga, M. Onaga, T. Hori, S. Hirono, K. Hayashi, T. Tamaoki, et al. Gene Therapy Targeting for Hepatocellular Carcinoma: Selective and Enhanced Suicide Gene Expression Regulated by a Hypoxia-inducible Enhancer Linked to a Human {{alpha}}-Fetoprotein Promoter Cancer Res., April 1, 2001; 61(7): 3016 - 3021. [Abstract] [Full Text]

				K. Fujimoto-Ouchi, Y. Tanaka, and T. Tominaga Schedule Dependency of Antitumor Activity in Combination Therapy with Capecitabine/5'-Deoxy-5-fluorouridine and Docetaxel in Breast Cancer Models Clin. Cancer Res., April 1, 2001; 7(4): 1079 - 1086. [Abstract] [Full Text]